vTv Therapeutics (VTVT) Long-Term Debt Issuances (2014 - 2025)
vTv Therapeutics (VTVT) reported Long-Term Debt Issuances of $328000.0 for Q4 2025, up 412.5% sequentially from $64000.0 in Q3 2025.
vTv Therapeutics (VTVT) Long-Term Debt Issuances (2014 - 2025) Analysis & Trends
vTv Therapeutics (VTVT) has 11 years of Long-Term Debt Issuances data on file, last reported at $328000.0 in Q4 2025.
- For the quarter ending Q4 2025, Long-Term Debt Issuances changed N/A year-over-year to $328000.0; the trailing twelve-month figure through Dec 2025 stood at $392000.0 (up 105.24% YoY), and the FY2025 full-year result was $392000.0, up 105.24% from the prior year.
- Long-Term Debt Issuances climbed to $328000.0 in Q4 2025, from $64000.0 in the prior quarter.
- In the past five years, Long-Term Debt Issuances ranged from a high of $803000.0 in Q3 2021 to a low of -$172000.0 in Q4 2021.
- A 5-year average of $220000.0 and a median of $221500.0 in 2022 frame the typical range for Long-Term Debt Issuances.
- Across the five-year window, Long-Term Debt Issuances plunged 103.47% in 2021 and surged 275.0% in 2022, its largest moves.
- Tracing VTVT's Long-Term Debt Issuances over 5 years: stood at -$172000.0 in 2021, then surged by 275.0% to $301000.0 in 2022, then retreated by 17.28% to $249000.0 in 2023, then slipped by 23.29% to $191000.0 in 2024, then surged by 71.73% to $328000.0 in 2025.
- Business Quant data shows VTVT's Long-Term Debt Issuances at $328000.0 in Q4 2025, $64000.0 in Q3 2025, and $191000.0 in Q1 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Issuances (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | vTv Therapeutics | 19.21 Mn | 19.21 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 328,000.00 |
| Dec 31, 2025 | 328,000.00 |
| Sep 30, 2025 | 64,000.00 |
| Sep 30, 2025 | 64,000.00 |
| Mar 31, 2024 | 191,000.00 |
| Mar 31, 2024 | 191,000.00 |
| Dec 31, 2023 | 249,000.00 |
| Dec 31, 2023 | 249,000.00 |
| Sep 30, 2023 | 93,000.00 |
| Sep 30, 2023 | 93,000.00 |
| Mar 31, 2023 | 224,000.00 |
| Mar 31, 2023 | 224,000.00 |
| Dec 31, 2022 | 301,000.00 |
| Dec 31, 2022 | 301,000.00 |
| Sep 30, 2022 | 219,000.00 |
| Sep 30, 2022 | 219,000.00 |
| Mar 31, 2022 | 256,000.00 |
| Mar 31, 2022 | 256,000.00 |
| Dec 31, 2021 | -172,000.00 |
| Dec 31, 2021 | -172,000.00 |